Tyra Biosciences Inc (TYRA)
18.33
+0.48
(+2.69%)
USD |
NASDAQ |
May 06, 16:00
Tyra Biosciences Price to Book Value: 4.713 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 4.713 |
| May 03, 2024 | 4.590 |
| May 02, 2024 | 4.764 |
| May 01, 2024 | 4.703 |
| April 30, 2024 | 4.397 |
| April 29, 2024 | 4.230 |
| April 26, 2024 | 4.029 |
| April 25, 2024 | 3.885 |
| April 24, 2024 | 4.114 |
| April 23, 2024 | 4.212 |
| April 22, 2024 | 3.986 |
| April 19, 2024 | 3.852 |
| April 18, 2024 | 3.770 |
| April 17, 2024 | 3.716 |
| April 16, 2024 | 3.771 |
| April 15, 2024 | 3.793 |
| April 12, 2024 | 3.829 |
| April 11, 2024 | 3.875 |
| April 10, 2024 | 3.944 |
| April 09, 2024 | 4.384 |
| April 08, 2024 | 4.397 |
| April 05, 2024 | 4.628 |
| April 04, 2024 | 4.628 |
| April 03, 2024 | 4.525 |
| April 02, 2024 | 4.315 |
| Date | Value |
|---|---|
| April 01, 2024 | 4.340 |
| March 28, 2024 | 4.217 |
| March 27, 2024 | 4.191 |
| March 26, 2024 | 4.153 |
| March 25, 2024 | 4.235 |
| March 22, 2024 | 4.299 |
| March 21, 2024 | 4.302 |
| March 20, 2024 | 4.466 |
| March 19, 2024 | 4.140 |
| March 18, 2024 | 4.173 |
| March 15, 2024 | 4.500 |
| March 14, 2024 | 4.549 |
| March 13, 2024 | 4.802 |
| March 12, 2024 | 4.846 |
| March 11, 2024 | 4.997 |
| March 08, 2024 | 5.041 |
| March 07, 2024 | 4.997 |
| March 06, 2024 | 5.054 |
| March 05, 2024 | 4.974 |
| March 04, 2024 | 5.125 |
| March 01, 2024 | 5.107 |
| February 29, 2024 | 5.123 |
| February 28, 2024 | 5.100 |
| February 27, 2024 | 5.041 |
| February 26, 2024 | 4.964 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7544
Minimum
Jun 17 2022
5.125
Maximum
Mar 04 2024
2.229
Average
2.179
Median
Oct 13 2021
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.823 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7463 |
| Theriva Biologics Inc | 0.1914 |
| Oragenics Inc | 3.498 |
Price to Book Value Related Metrics
| Price | 18.33 |
| Earnings Yield | -8.78% |
| Market Cap | 962.71M |